Skip to content

Epidaurus · Treatment Guide · Reproductive Services

Going abroad for —

Fertility Technology

Advanced techniques including ICSI, time-lapse monitoring, assisted hatching

The country comparison

Which countries are best for fertility technology

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 Singapore SG 5.0/5 Good Singapore operates at the frontier of fertility technology with comprehensive advanced techniques routinely available at major clinics. EmbryoScope+ time-lapse monitoring, multiple sperm selection modalities (IMSI, PI... Full report
    The evidence behind this score 7 cited points
    • EmbryoScope+ time-lapse monitoring widely deployed across major private clinics (Virtus, Mount Elizabeth, Monash IVF, Alpha IVF Singapore) enabling continuous non-disruptive embryo assessment
    • Multiple advanced sperm selection techniques available: IMSI at Virtus, PICSI and Piezo-ICSI at Monash, microfluidic sperm sorting at Alpha IVF, MACS at Mount Elizabeth
    • Vitrification outcomes: 100% post-thaw embryo survival at Alpha IVF since July 2024; 72.5% clinical pregnancy rate per frozen blastocyst transfer for patients aged 34 and below
    • Laboratory infrastructure: ISO 14644 clean room standards at Virtus, RTAC Code of Practice adopted as national standard under HCSA licensing, RFID-based electronic sample tracking
    • AI-integrated embryo assessment at Alpha IVF using deep-learning algorithms trained on tens of thousands of time-lapse sequences; Alpha IVF Group won Healthcare Asia Technology Innovation of the Year 2024
    • World-first clinical achievement: KKIVF achieved live birth from oocyte maturation using ovarian tissue from cancer patient, demonstrating advanced micromanipulation capabilities
    • Government innovation investment: NUS Mechanobiology Institute S$49 million funding for fertility-related biomedical research; S$37 billion RIE2030 plan includes biomedical sciences

    Read the full Singapore report →

  2. 2 Poland PL 5.0/5 Good Poland demonstrates comprehensive advanced fertility technology across major clinic networks, including routine time-lapse EmbryoScope monitoring (deployed at 8 of 11 Klinika Bocian locations, both TFP Poland sites, a... Full report
    The evidence behind this score 7 cited points
    • EmbryoScope time-lapse monitoring deployed across major networks: 8 of 11 Klinika Bocian locations, both TFP Poland sites, INVICTA, Gameta, and FertiMedica
    • Advanced sperm selection technologies (IMSI and PICSI) available at multiple major networks: Gyncentrum, Invimed, TFP Poland, NOW-fertility, and INVICTA
    • Proprietary AI systems with peer-reviewed publication: INVICTA's AIOO® and GPS™ published in PLOS Computational Biology (2023), Gyncentrum's embryo evaluation algorithm processing 1,500+ developmental photographs
    • High laboratory standards: ISO 15189 (PN-EN) compliance via PCA certificates, ESHRE ART Centre Certification at three major Polish clinic networks, electronic identity verification systems (RI Witness, IMT Matcher)
    • Vitrification technology: Cryotop-method survival rates 90–97% for oocytes, with FET clinical pregnancy confirmation rates at 46%
    • Innovation and adoption: Gameta introduced vitrification, time-lapse monitoring, and low-oxygen incubation to Polish clinical practice first; INVICTA conducts 300+ research studies annually; Gyncentrum performed Poland's first IMSI procedure in 2006 (over a decade before mainstream adoption)
    • International comparison: Technology functionally equivalent to Western European standards at 40–60% lower cost; government 2024–2028 IVF funding program driving technology investment

    Read the full Poland report →

  3. 3 Spain ES 5.0/5 Good Spain meets and exceeds all Score 5 criteria for fertility technology. All major clinics deploy routine time-lapse monitoring systems (EmbryoScope Plus, Geri, MIRI TL), offer advanced sperm selection including IMSI at... Full report
    The evidence behind this score 5 cited points
    • Time-lapse monitoring deployed as standard at all major Spanish fertility groups with multiple systems (EmbryoScope Plus, Geri, MIRI TL, EmbryoScope Flex) [Embryo Culture and Monitoring Systems - reports/research/es/fertility_technology.md]
    • Advanced sperm selection technologies routinely available: ICSI standard, IMSI at 8,000× magnification (Barcelona IVF), MACS (FIV Valencia), and microfluidic sorting [Advanced Sperm Selection and Injection Technologies - reports/research/es/fertility_technology.md]
    • Vitrification success rates exceed 85% threshold: 97.5% blastocyst survival rate post-warming at IVI Valencia (846 blastocysts, 2022-2024), with 40.3% live birth rate per transferred embryo [Embryo Manipulation and Enhancement Techniques - reports/research/es/fertility_technology.md]
    • Laboratory standards exceed ISO 15189+ requirements: multi-layered certification via UNE 179007 (Spain-specific ART standard), ISO 9001, ESHRE Centre of Excellence accreditation, and ASEBIR external quality control program since 2003 [Laboratory Technology and Equipment Standards - reports/research/es/fertility_technology.md]
    • Proprietary AI systems for embryo selection: IVI's IA EmbryoSelect achieves 6-8% pregnancy rate improvement, up to 18% for morphologically similar embryos; Instituto Bernabeu's VRepro Witness digital traceability with mandatory double verification [Artificial Intelligence and Digital Integration - reports/research/es/fertility_technology.md]

    Read the full Spain report →

  4. 4 South Korea KR 5.0/5 Good South Korea demonstrates comprehensive advanced fertility technologies that fully meet Score 5 criteria. Major fertility centers routinely offer AI-integrated time-lapse embryo monitoring (Vita Embryo system achieving... Full report
    The evidence behind this score 8 cited points
    • State-of-the-art AI time-lapse embryo monitoring systems with Vita Embryo medical device certification in Europe, Singapore, Korea, and India, with clinical tests indicating AI-powered system can double accuracy of embryo selection compared to human evaluation
    • ICSI routine procedure at 49.4% of fresh embryo transfer cycles with advanced sperm selection techniques (SpermSlow, IMSI, PICSI) available at leading centers
    • ISO-certified laboratories with JCI (Joint Commission International) accreditation, Korean Society for Reproductive Medicine, and Korean Society for Assisted Reproduction certification maintaining stringent international standards
    • World's first vitrification method for egg freezing developed by CHA Hospital in 1998, with CHA conducting over 90,000 IVF procedures annually and possessing the largest biobank in the country
    • Laser-assisted hatching using ultra-precision laser equipment for zona pellucida manipulation, representing latest technology in embryo enhancement techniques
    • Rapid adoption of innovative AI-integrated embryo selection systems from domestic technology firm Kai Health, demonstrating quick integration of cutting-edge solutions into clinical practice
    • CHA Fertility Center - Seoul Square is the largest single IVF specialty facility in the world with 6,611 m² floor space, providing extensive infrastructure for advanced technologies
    • No documented restrictions on international patients accessing advanced technologies, with multilingual support and tailored VIP services for foreign patients

    Read the full South Korea report →

  5. 5 United Kingdom GB 5.0/5 Good The UK offers comprehensive advanced fertility technologies at a world-leading level. All major centers provide routine time-lapse embryo monitoring, advanced sperm selection techniques (IMSI, PICSI), AI-integrated em... Full report
    The evidence behind this score 6 cited points
    • Time-lapse embryo monitoring (EmbryoScope, GERI, Primo Vision) deployed as standard or readily available at majority of leading UK private fertility clinics
    • ICSI universally available; IMSI offered at Lister Fertility, Cambridge IVF, TFP Fertility; PICSI at Fertility Academy London and TFP Fertility
    • Vitrification thaw survival consistently 90–95% at modern UK facilities; frozen embryo transfer pregnancy rate 39% nationally in 2023
    • AI-integrated embryo selection systems (Caremaps Ai trained on 60,000+ embryo journeys; iDAScore v2.0) deployed across major clinic networks
    • UK only country to legislate for and clinically implement mitochondrial donation treatment with eight healthy babies born as of 2025; Newcastle Fertility Centre holds world's only national MDT license
    • All 107 HFEA-licensed treatment clinics subject to biennial inspections with Code of Practice integrating ISO 9001 and ISO 15189 standards; ARCS published comprehensive updated good practice guidelines May 2024

    Read the full United Kingdom report →

  6. 6 Malaysia MY 5.0/5 Good Malaysia's leading fertility centres offer comprehensive advanced technologies matching or exceeding international standards, including routine time-lapse monitoring with AI integration at major clinics, multiple adva... Full report
    The evidence behind this score 5 cited points
    • Time-lapse embryo monitoring deployed as standard at six major clinic networks (Alpha IVF, Sunfert, Genesis IVF, Avisena, Thomson Fertility, Sunway Fertility)
    • Advanced sperm selection techniques including IMSI (up to 6,000-7,000× magnification), PICSI, Piezo-ICSI, and microfluidic sperm selection routinely offered at multiple named centres
    • AI-assisted embryo selection operational at Alpha IVF Group, Genesis IVF, and Thomson Fertility, integrated with time-lapse imaging
    • Vitrification success rates exceeding 85% across multiple centres; Alpha IVF achieved 100% survival across 10,290 consecutive embryos (Cryotec® protocol, Malaysia Book of Records)
    • Malaysia hosts 10 of 30 globally RTAC-certified fertility centres, with multiple clinics holding ISO 9001:2015 or equivalent certification

    Read the full Malaysia report →

  7. 7 Thailand TH 5.0/5 Good Thailand's leading fertility clinics offer comprehensive advanced fertility technologies matching or exceeding international standards. SAFE Fertility Group holds RTAC accreditation (first in Thailand, second in ASEAN... Full report
    The evidence behind this score 8 cited points
    • SAFE Fertility Group holds RTAC accreditation from Australia and New Zealand—the first IVF clinic in Thailand and second in ASEAN to receive this prestigious certification
    • Leading fertility clinics employ EmbryoScope Plus time-lapse incubator technology at major centers including SAFE Fertility Group, Vejthani Hospital's VFC Center, and Genea Clinic
    • Advanced sperm selection technologies (IMSI by Leica with 6000x magnification) widely available; 10+ rated ICSI with IMSI facilities documented
    • Vitrification technology achieves egg thaw survival rates over 90%, significantly exceeding the 85% threshold for Score 5
    • AI algorithms and CNN models developed locally for embryo analysis and pregnancy prediction; Thailand actively participates in AI fertility technology development
    • Over 90% of fertility specialists in Bangkok's leading clinics hold international certifications from the US, UK, or Australia
    • Thailand maintains 38 JCI-accredited hospitals—more than any other Southeast Asian country—ensuring high laboratory standards
    • Rapid adoption of innovative techniques including introduction of PGTSeq-A genetic testing and NGS sequencing across leading centers

    Read the full Thailand report →

  8. 8 United States US 5.0/5 Good The United States represents the global leader in advanced fertility technology, comprehensively meeting all Score 5 criteria. Time-lapse monitoring (EmbryoScope) is routinely available at major clinics with 300,000+ ... Full report
    The evidence behind this score 5 cited points
    • Time-lapse EmbryoScope monitoring used in 300,000+ patient treatments nationwide since 2009, routine at all major centers
    • ICSI fertilization rates average 70-80%; IMSI achieves >85% in severe male factor cases; PICSI available at major centers
    • 62% of SART-registered centers introduced AI embryo morphology scoring systems by 2024, with 70-97% accuracy in embryo selection and 6.4 percentage point increase in singleton live birth rate for patients over 35
    • Vitrification survival rate >95% with freeze-all VFET achieving implicit pregnancy rates up to 84%, far exceeding 85% success threshold
    • CAP Reproductive Accreditation Program recognized by SART as meeting membership requirements, with on-site inspections every two years and 86% of US IVF clinics maintaining SART membership accounting for 95% of all IVF cycles

    Read the full United States report →

  9. 9 United Arab Emirates AE 4.5/5 Good The UAE demonstrates world-class fertility technology infrastructure with routine time-lapse monitoring (EmbryoScope/Plus) at major clinics, advanced sperm selection techniques (ICSI/IMSI/PICSI/microfluidic), sophisti... Full report
    The evidence behind this score 6 cited points
    • Time-lapse embryo monitoring (EmbryoScope/Plus) deployed routinely at Fakih IVF, ART Fertility, Orchid Fertility, and Corniche Fertility Centre (May 2026)
    • Advanced sperm selection: IMSI available with 6000× magnification, PICSI available for sperm DNA fragmentation cases, microfluidic sperm sorting offered at select Dubai clinics
    • AI-integrated embryo selection: Vitrolife iDAScore deployed at Corniche Fertility Centre (May 2026, first regional deployment in public hospital network); ART Fertility's 14,776-embryo EmbryoScope dataset contributing to ML model development
    • Laboratory quality assurance: Bourn Hall UAE (3 sites) holds CAP accreditation; Orchid Fertility holds CAP and JCI; First IVF and Bourn Hall hold JCI accreditation; DHA Standards (November 2024) mandate ILAC-registered laboratory accreditation
    • Rapid technology adoption: Fakih pioneered UAE's first EmbryoScope and MicroTESE; Orchid pioneered non-invasive PGT (niPGT); Corniche deployed AI embryo ranking in May 2026; progression from ICSI to AI-integrated scoring across ~15 years demonstrates substantial systemic investment
    • Vitrification technology: 80%+ of UAE ART transfers now cryopreserved; Bourn Hall employs vitrification with "high survival rates" but specific success rate percentages not published; report explicitly notes vitrification survival rate data is limited

    Read the full United Arab Emirates report →

  10. 10 Colombia CO 4.5/5 Good Colombia demonstrates excellent fertility technology sophistication with comprehensive availability of advanced techniques including routine time-lapse monitoring, AI-integrated embryo selection, advanced sperm select... Full report
    The evidence behind this score 6 cited points
    • Time-lapse monitoring (EmbryoScope+) routinely deployed at Reprotec, Clínica Imbanaco, and other major clinics; Reprotec pioneered this technology in Colombia over 10 years ago
    • Advanced sperm selection available: IMSI at InSer since 2012, MACS at IVI Cartagena, microfluidic sperm sorting documented at REDLARA 2023 workshop
    • AI integration at frontier level: Fertilidad Integral first clinic outside US to adopt Alife Health Embryo Predict™; Reprotec deployed Folliscan AI for ultrasound analysis
    • Laboratory accreditation: InSer holds JCI Ambulatory Care (2025, first in Colombia), REDLARA Gold Seal, AAAASF, GHA; Reprotec holds ISO 9001; Witness RFID sample tracking at Reprotec
    • Vitrification success rates above 95% reported; freeze-all strategy with frozen embryo transfer actively promoted
    • Full technology parity for international patients with no restrictions; multiple clinics explicitly serve medical tourism with dedicated international programs

    Read the full Colombia report →

  11. 11 Germany DE 4.5/5 Good Germany offers elite-level fertility technology including universal ICSI, widely available IMSI/PICSI/ZyMot sperm selection, time-lapse monitoring at major clinics (>50% of urban centers), AI-integrated embryo scoring... Full report
    The evidence behind this score 6 cited points
    • Advanced sperm selection technologies routinely available: IMSI at CERES Berlin (6,600× magnification), PICSI at Wunschkinder Berlin and IVF Dresden, ZyMot microfluidic sorting at Dresden
    • Time-lapse embryo monitoring (EmbryoScope) in active clinical use at major fertility clinics (Berlin, Dresden); >50% of urban German fertility centers offer time-lapse monitoring with documented 10%+ pregnancy rate improvement
    • Vitrification technology at highest standard: >97-98% embryo survival rates reported by leading centers; national data shows near-equivalent fresh (31.0%) vs. frozen (30.7%) pregnancy rates, reflecting mastery of cryopreservation
    • Laboratory standards exceed international benchmarks: DIN EN ISO 14644-1 Class 9 clean rooms, ISO 9001:2015 TÜV certification, DAkkS/ISO 15189 accreditation, biannual QuaDeGe andrology external quality validation, 97% of ~131 clinics participate in D·I·R registry
    • AI integration present: iDAScore (deep-learning algorithm) integrated with EmbryoScope+ for automated embryo ranking and selection
    • Regulatory constraint rather than technology gap: ESchG (1990) caps embryo creation at 3 per cycle, limiting blastocyst cohort selection strategies compared to less-restrictive jurisdictions; egg donation prohibited, same-sex female couples face clinic-level restrictions outside Berlin

    Read the full Germany report →

  12. 12 Israel IL 4.5/5 Good Israel offers comprehensive advanced fertility technologies including routine time-lapse embryo monitoring at all major centres, universal ICSI with advanced sperm selection (IMSI/PICSI), sophisticated embryo culture ... Full report
    The evidence behind this score 4 cited points
    • Time-lapse monitoring via EmbryoScope deployed routinely at all major centres (Sheba, Rambam, Assuta, Ichilov) with AI integration at Sheba
    • Three Israeli companies (AIVF, Fairtility, QART Medical) developed globally-licensed AI embryo/sperm selection platforms; QART Q300™ showed 100% improvement in clinical pregnancies in clinical trials
    • Sheba Medical Center achieved ISO 15189 accreditation in August 2024; Sheba, Assuta, and Ichilov hold JCI accreditation
    • 65% IVF success rate for women under 35 with >95% embryo survival rates from modern vitrification protocols; 52,000+ annual IVF cycles (highest per capita globally)

    Read the full Israel report →

  13. 13 Japan JP 4.5/5 Good Japan demonstrates most fertility technologies available including exceptional vitrification (>95% post-thaw success via Cryotop®, exceeding Score 5 thresholds), dominant ICSI with pioneering Piezo-ICSI innovation, so... Full report
    The evidence behind this score 7 cited points
    • Vitrification technology >95% post-thaw blastocyst survival using Cryotop® method (Japan-originated, used in 115 countries)
    • ICSI dominant with 195,657 cycles (68.7% of 2023 cycles); Piezo-ICSI standard at leading clinics (Japan-originated innovation reducing oocyte lysis)
    • Time-lapse monitoring at 54.6% of ART facilities with 31% of TLT-equipped centers combining AI-based embryo scoring (Kato Ladies Clinic partnership with Future Fertility for commercial oocyte assessment)
    • Assisted hatching exceptionally widespread at 85.1% of facilities (94.2% at private clinics)
    • Embryologist staffing: only 44.6% of Japanese ART facilities meet ASRM minimum standards, creating quality inequalities between high-volume private clinics and smaller/hospital-based facilities
    • IMSI adoption limited at 15.5% of facilities, substantially below leading European fertility centers
    • International access available at major clinics (Kato, Sugiyama, Oak, Sanno) but limited by language barriers at majority of Japanese centers

    Read the full Japan report →

  14. 14 Mexico MX 4.5/5 Good Mexico's leading fertility clinics offer nearly comprehensive advanced technologies meeting or exceeding Score 5 criteria: ICSI (70% of cycles), PICSI, IMSI, PIEZO sperm selection; routine time-lapse embryo monitoring... Full report
    The evidence behind this score 6 cited points
    • Time-lapse embryo monitoring systems (EmbryoScope) widely used at major Mexico City, Guadalajara, and Puerto Vallarta clinics for continuous embryo assessment
    • Advanced sperm selection routinely available: ICSI in ~70% of cycles, PICSI using hyaluronic acid binding, IMSI, PIEZO-assisted ICSI, and MicroSort technology at LIV Fertility Center
    • Vitrification success rates of 80-99%: Puntamita Fertility Center achieves ~80% egg survival and 50%+ pregnancy rates; some clinics report up to 99% survival vs 55% with traditional freezing
    • Mexico is global AI leader in fertility: Fertilidad Integral was first international clinic to implement Embryo Predict™ AI-powered embryo grading; AURA robotic system at Hope IVF demonstrated 51% success rate and world-class outcomes
    • Laboratory standards include COFEPRIS regulatory oversight, ISO certification, RedLara accreditation, and specialized monitoring systems (PharmaWatch, RI Witness RFID tracking, HEPA filtration)
    • Rapid technology adoption confirmed through partnerships: Vitrolife AB, Merck KGaA, FUJIFILM Irvine Scientific, CooperSurgical all deploying next-generation technologies in Mexico

    Read the full Mexico report →

  15. 15 Turkey TR 4.5/5 Good Turkey demonstrates exceptional fertility technology infrastructure meeting or exceeding nearly all Score 5 criteria. The country offers routine time-lapse monitoring (Embryoscope), advanced sperm selection techniques... Full report
    The evidence behind this score 7 cited points
    • Bahçeci Fertility holds ESHRE certification—the only center in Turkey and one of only eight IVF centers worldwide with this prestigious certification
    • Vitrification survival rates of 98-100% at leading centers like Anatolia IVF, with live birth rates in frozen embryo replacement cycles matching or exceeding fresh transfers
    • IMSI technology routinely available using high-magnification digital imaging microscopes magnifying sperm up to 6,000 times; PICSI available at leading centers like Liv Hospital
    • Time-lapse Embryoscope monitoring widely employed at major Turkish clinics and often included in standard IVF packages
    • Blastocyst culture routine with leading centers freezing only on Day 5/6 and high blastocyst transfer rates; Anadolu IVF achieves 50% blastocyst transfer rate
    • Six-month government inspection by Turkish Ministry of Health plus annual audits at leading centers by embryology experts, ensuring rigorous quality control
    • Memorial pioneered multiple technologies in Turkey including ICSI, embryo freezing, blastocyst transfer, and was first to achieve pregnancy using ICSI microinjection technique

    Read the full Turkey report →

  16. 16 India IN 4.0/5 Good India demonstrates good fertility technology capabilities with a comprehensive portfolio including time-lapse monitoring at major clinics, ICSI with advanced sperm selection (IMSI/PICSI), established blastocyst cultur... Full report
    The evidence behind this score 6 cited points
    • Time-lapse embryo monitoring available at major clinics including Cloudnine Fertility and Akanksha IVF Centre, though not yet universal across all centers
    • Advanced sperm selection technologies: ICSI with 80-85% fertilization rates, IMSI available at Bloom IVF (first in India, 2007) with locations in Mumbai/Delhi/Chandigarh, and PICSI available at specialized centers
    • Nova IVF rolled out Vita Embryo AI-powered embryo assessment technology across 104 clinics; AI increases embryo selection precision by 12% and can double accuracy compared to human evaluation
    • Embryo survival rates of 90-95% after vitrification thawing; FET success rates range from 50-70% per cycle depending on clinic expertise
    • Ferty9 operates Class 1000 clean room laboratory (one of few in India); Class 10,000 facilities available with HEPA filtration and biannual particle counts
    • Significant variation: approximately 3000 IVF clinics in India with advanced technologies concentrated in premium metropolitan centers; laboratory accreditation is voluntary rather than mandatory

    Read the full India report →

  17. 17 Brazil BR 4.0/5 Good Brazil offers most advanced fertility technologies at major clinics, including ICSI (95.1% availability), time-lapse monitoring at flagship centers, sophisticated blastocyst culture (80.8% in frozen cycles), and excep... Full report
    The evidence behind this score 5 cited points
    • ICSI available at 95.1% of Brazilian clinics; FertGroup controls ~50-60% of all embryoscopes nationwide with EmbryoScope Plus time-lapse systems [Assisted Reproductive Technologies in Brazil - PMC - 2020]
    • Vitrification survival rates of 97% at top facilities; 40% of IVF market uses frozen embryo transfers; 80.8% blastocyst transfer rate in frozen cycles (REDLARA 2019 registry) [Impact of embryo storage time after vitrification - PMC - 2025]
    • Domestic AI embryo selection innovation: MAIA platform developed at Huntington São Paulo (Scientific Reports 2025); FertGroup deployed VIOLET/MAGENTA oocyte assessment network-wide April 2024 as first in Latin America [MAIA platform - Scientific Reports - 2025; FertGroup + Future Fertility - FemTech World - April 2024]
    • Advanced sperm selection (IMSI, PICSI, ZyMOT) available at leading São Paulo centers (Neo Vita, Huntington); geographic concentration with 55% of market in Southeast region limits nationwide uniformity [Brazil IVF Market - IMARC - 2025]
    • Multi-layer laboratory regulation via ANVISA RDC 771/2022, CFM Resolution 2.320/2022, REDLARA accreditation (~50% of clinics), ISO 9001 at leading centers; Chedid Grieco holds rare FDA + NYDH tissue licensure equivalent to US standards [Comparative analysis of ethical standards - PMC - 2025]

    Read the full Brazil report →

  18. 18 Hungary HU 3.5/5 Moderate Hungary's leading fertility centres (Pesterzsébeti, Semmelweis ARC) offer most Score 4 technologies: time-lapse monitoring at select major clinics, advanced sperm selection (PICSI, Zymot microfluidic sorting), sophist... Full report
    The evidence behind this score 4 cited points
    • Pesterzsébeti Reprodukciós Intézet offers time-lapse embryo monitoring, PICSI, Zymot/Fertile chip microfluidic sperm selection, and advanced blastocyst vitrification capabilities
    • Semmelweis University ARC achieves 98% post-thaw embryo survival and performs >90% of transfers at day-5 blastocyst stage, indicating sophisticated embryo culture protocols
    • ISO 15189 accreditation is legally mandatory for all Hungarian medical laboratories; former Versys Clinics HRI held ESHRE ARTCC certification (one of only four clinics globally)
    • Post-2022 state monopoly has slowed technology adoption: overall IVF success rates declined from 19% (2019) to approximately 16% (2021), below EU average of 33%, indicating reduced competitive pressure for technology investment

    Read the full Hungary report →

  19. 19 Jordan JO 3.5/5 Moderate Jordan's leading private fertility clinics demonstrate most advanced technologies expected of good medical tourism destinations—including confirmed time-lapse embryo monitoring (EmbryoScope and MIRI systems at major c... Full report
    The evidence behind this score 4 cited points
    • EmbryoScope time-lapse embryo monitoring confirmed at Specialty Hospital's flagship fertility center; MIRI® Multiroom Incubator at Amman Hospital; Hamilton Thorne LYKOS® laser-assisted hatching systems available through equipment suppliers
    • Specialty Hospital holds ISO 15189 (medical laboratory), JCI (6th consecutive renewal 2023), HCAC, and MTQUA accreditation; Istishari Hospital holds JCI and HCAC certification; both exceed 'good' laboratory standard requirements
    • No Jordanian fertility clinic publicly confirmed adoption of AI embryo selection platforms (iDAScore, Life Whisperer, Embryo Intelligence); described as a material gap relative to leading ART destinations
    • Assisted hatching routinely available at Specialty Hospital and Hiba Hospital; ICSI universal across all major centers; embryo cryopreservation and vitrification routine at multiple leading centers; sperm DNA fragmentation testing available

    Read the full Jordan report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for fertility technology, top to bottom. How we score →

  1. 5/5 Excellent

    Country offers comprehensive advanced fertility technologies including: routine time-lapse monitoring at major clinics, advanced sperm selection techniques (IMSI/PICSI), sophisticated embryo culture systems, AI-integrated embryo selection, high-standard clean room facilities (ISO 15189+), vitrification success rates >85%, and rapid adoption of innovative techniques. Leading fertility clinics match or exceed international technology standards.

  2. 4/5 Good

    Most fertility technologies available including: time-lapse monitoring at some major clinics, ICSI with enhanced sperm selection options, quality embryo culture capabilities, assisted hatching routinely available, good laboratory standards (ISO certified), vitrification success rates 75-85%, and reasonable technology adoption timelines. Technology levels comparable to developed medical tourism destinations.

  3. 3/5 Moderate

    Basic advanced technologies available including: ICSI widely available, some time-lapse monitoring systems, standard embryo culture protocols, assisted hatching selectively available, adequate laboratory quality control, vitrification success rates 60-75%, and technology adoption lags 2-3 years behind leading countries. Sufficient for standard complex cases.

  4. 2/5 Poor

    Limited advanced technologies including: ICSI available but not routine, minimal time-lapse monitoring, basic embryo culture capabilities, inconsistent laboratory standards, vitrification success rates 45-60%, and slow technology adoption. Technology limitations may affect success rates for complex fertility cases.

  5. 1/5 Very Poor / Unavailable

    Very limited fertility technologies including: ICSI rarely available, no time-lapse monitoring, basic laboratory facilities, poor quality control systems, vitrification success rates <45%, and minimal access to modern fertility technologies. Significant technological limitations that substantially impact treatment success potential.

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source redlara.com/aa_ingles/registro.asp Cited in Fertility Technology in Mexico
  2. Untitled source www.reproductive-solutions.com/clinics/mexico.html Cited in Fertility Technology in Mexico
  3. Untitled source www.thailawforum.com/medical-surrogacy-regulations Cited in Fertility Technology in Thailand
  4. Untitled source adorefertility.com/cutting-edge-fertility-treaments Cited in Fertility Technology in United States
  5. Untitled source adorefertility.com/latest-advances-in-fertility-treatments-for-2025 Cited in Fertility Technology in United States
  6. Untitled source aikyafertility.com/imsi-and-picsi.html Cited in Fertility Technology in India
  7. Untitled source aivf.co Cited in Fertility Technology in South Korea, Fertility Technology in United States, Fertility Technology in Turkey
  8. Untitled source aivf.co/ema-platform Cited in Fertility Technology in Israel
  9. Untitled source akankshaivfcentre.com Cited in Fertility Technology in India
  10. Untitled source appdb.tisi.go.th/tis_devs/tislab/labgroup_eng.php Cited in Fertility Technology in Thailand
  11. Untitled source archive.cdc.gov/www_cdc_gov/art/reports/2019/pdf/2019-Report-ART-Fertility-Clinic-National-Summary-h.pdf Cited in Fertility Technology in United States
  12. Untitled source artfertilityclinics.in/infertility-treatment/frozen-embryo-transfers-fet Cited in Fertility Technology in India
  13. Untitled source ayuhfertilitycentre.com/latest-advances-in-ivf-technology Cited in Fertility Technology in India
  14. Untitled source bangkokfertilitycenter.com/blog/icsi-cost-in-bangkok Cited in Fertility Technology in Thailand
  15. Untitled source bangkokfertilitycenter.com/blog/ivf-success-rate-in-bangkok Cited in Fertility Technology in Thailand
  16. Untitled source bangkokfertilitycenter.com/blog/ivf-success-rate-in-thailand Cited in Fertility Technology in Thailand
  17. Untitled source bccivfwellness.com Cited in Fertility Technology in Thailand
  18. Untitled source bccivfwellness.com/bangkok-fertility-treatment-destination Cited in Fertility Technology in Thailand
  19. Untitled source bccivfwellness.com/bangkok-vs-global-ivf Cited in Fertility Technology in Thailand
  20. Untitled source bccivfwellness.com/treatment-services/icsi-treatment-bangkok Cited in Fertility Technology in Thailand
  21. Untitled source bestclinicabroad.com/en/clinics/south-korea/reproductive-medicine Cited in Fertility Technology in South Korea
  22. Untitled source bestivftreatment.in/blog/icsi-success-rates-risks-and-benefits Cited in Fertility Technology in India
  23. Untitled source bken.loadskill.com/usivf/365.html Cited in Fertility Technology in United States
  24. Untitled source bloomclinicsobo.com/blog/understand-the-chances-of-pregnancy-after-blastocyst-transfer Cited in Fertility Technology in India

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Reproductive Services

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Fertility Technology

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison